There were no significant differences between two groups in terms of age, cancer staging, histopathology, tumor grading, lymphovascular invasion, extracapsular nodal extension, ER, PR, HER2, type of chemotherapy, chemotherapy regimen, and hormonal treatment. Here, ERBB2 is linked to cancer.